EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion

Namra Ajmal iD, Stacey M Gargano, Ujwala Gosavi, Madalina Tuluc

International Journal of Genomics · 2024-01 · 2024 (1)

DOI: 10.1155/2024/4937501 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Genomics, online erschienen am 14.08.2024. Verfasst von Namra Ajmal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Genomic Medicine Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory myofibroblastic tumor (IMT) is a rare soft tissue tumor primarily occurring in the abdominopelvic region of young patients, and it is characterized by spindle‐shaped myofibroblasts, or fibroblasts surrounded by inflammatory infiltrate. Herein, we report a case of a 24‐year‐old male with a firm submucosal mass in the anterior right vocal fold diagnosed as an IMT that recurred 14 months later. The tumor demonstrated a novel THBS1::ALK fusion containing Exons 1–7 of the thrombospondin 1 ( THBS1 ) gene fused to Exon 19 of the anaplastic lymphoma kinase ( ALK ) gene via next‐generation sequencing with the NextSeq sequencer. The fusion of THBS1 to ALK potentially results in increased expression and constitutive activation of the ALK kinase domain. These findings not only broaden the repertoire of known ALK fusion partners implicated in tumorigenesis but also provide a novel avenue for investigating the etiology of recurrent IMT by considering this fusion event as a causal factor. To our knowledge, this is the second case of IMT of the larynx with this novel mutation reported in the literature and the first such case with a detailed description of this specific fusion and clinical recurrence.

Schlagwörter

Stichwörter der Autor:innen

ALK fusionIMTInflammatory myofibroblastic tumorTHBS1larynx

Autor:innen und Institutionen

  • Department of Pathology and Genomic Medicine Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

ORCID-Profile: Namra Ajmal

Zitieren

APA

Ajmal, N., Gargano, S. M., Gosavi, U., & Tuluc, M. (2024). Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion. International Journal of Genomics, 2024(1). https://doi.org/10.1155/2024/4937501

Vancouver

Ajmal N, Gargano SM, Gosavi U, Tuluc M. Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion. International Journal of Genomics. 2024;2024(1). doi:10.1155/2024/4937501

BibTeX
@article{Ajmal2024,
  author = {Ajmal, Namra and Gargano, Stacey M and Gosavi, Ujwala and Tuluc, Madalina},
  title = {Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion},
  journal = {International Journal of Genomics},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/4937501}
}
Kostenlos starten →